bluebird bio, Inc. Depreciation and Amortization
bluebird bio, Inc. reported Depreciation and Amortization of $60.30 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2025-03-27
- bluebird bio, Inc. depreciation, depletion and amortization for fiscal 2024 was $60.30M, a 115.36% increase from fiscal 2023.
- bluebird bio, Inc. depreciation, depletion and amortization for fiscal 2023 was $28.00M, a 241.46% increase from fiscal 2022.
- bluebird bio, Inc. depreciation, depletion and amortization for fiscal 2022 was $8.20M, a 67.35% increase from fiscal 2021.
- bluebird bio, Inc. depreciation, depletion and amortization for fiscal 2021 was $4.90M, a 3.92% decline from fiscal 2020.
| Period end | Depreciation, Depletion and Amortization 12 month | Depreciation, Depletion and Amortization 12 month as first filed |
|---|---|---|
| 2024-12-31 | $60.30M 10-K · filed 2025-03-27 | |
| 2023-12-31 | $28.00M 10-K · filed 2025-03-27 | |
| 2022-12-31 | $8.20M 10-K · filed 2024-09-13 | $4.90M 10-K · filed 2023-03-29 |
| 2021-12-31 | $4.90M 10-K · filed 2023-03-29 | |
| 2020-12-31 | $5.10M 10-K · filed 2023-03-29 | $15.10M 10-K · filed 2021-02-23 |
| 2019-12-31 | $4.10M 10-K · filed 2022-03-04 | $13.40M 10-K · filed 2020-02-18 |
| 2018-12-31 | $13.40M 10-K · filed 2021-02-23 | |
| 2017-12-31 | $9.80M 10-K · filed 2020-02-18 | |
| 2016-12-31 | $5.90M 10-K · filed 2019-02-21 | |
| 2015-12-31 | $3.70M 10-K · filed 2018-02-21 | |
| 2014-12-31 | $2.30M 10-K · filed 2017-02-22 | |
| 2013-12-31 | $900.00K 10-K · filed 2016-02-25 | $941.00K 10-K · filed 2014-03-05 |
| 2012-12-31 | $300.00K 10-K · filed 2015-02-25 | $301.00K 10-K · filed 2014-03-05 |
| 2011-12-31 | $205.00K 10-K · filed 2014-03-05 |